2017
DOI: 10.1159/000455145
|View full text |Cite
|
Sign up to set email alerts
|

Expression and Clinical Significance of SOX9 in Renal Cell Carcinoma, Bladder Cancer and Penile Cancer

Abstract: Background: Novel molecular markers are important diagnostic tools for the assessment of cancer progression and evaluation of effectiveness of the treatment. SOX9, a key regulator of developmental processes, is overexpressed in various neoplasms, such as prostate, breast, and colorectal cancers. However, the utilization of SOX9 as a biomarker for other urological cancers has not yet been investigated. Methods: In the present study, paired patient tissue microarrays were analyzed by immunohistochemistry, and th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
19
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 21 publications
(21 citation statements)
references
References 24 publications
(25 reference statements)
2
19
0
Order By: Relevance
“…In addition, we evaluated the expressions of some SOX members including SOX4, SOX9 and another two SOXD members (SOX5 and SOX13) in ccRCC. In consistent with previous studies, 28,29 the mRNA levels of SOX4 and SOX9 were significantly upregulated in ccRCC tissues compared with adjacent nontumorous tissues (Figure S1A,B). However, there was no significant difference in the expressions of SOX5 and SOX13 between ccRCC and nontumorous tissues from TCGA dataset (Figure S1C,D).…”
Section: Resultssupporting
confidence: 92%
See 3 more Smart Citations
“…In addition, we evaluated the expressions of some SOX members including SOX4, SOX9 and another two SOXD members (SOX5 and SOX13) in ccRCC. In consistent with previous studies, 28,29 the mRNA levels of SOX4 and SOX9 were significantly upregulated in ccRCC tissues compared with adjacent nontumorous tissues (Figure S1A,B). However, there was no significant difference in the expressions of SOX5 and SOX13 between ccRCC and nontumorous tissues from TCGA dataset (Figure S1C,D).…”
Section: Resultssupporting
confidence: 92%
“…Because SOX6 has been shown to co‐stimulate SOX9 target genes (Col2a1 and Agc1) in chondrocytes 39 and SOX9 is involved in ccRCC growth, 29,32 it is possible that the role of SOX6 is ccRCC is in part due to regulation of SOX9 target genes. To test this hypothesis, we investigated the impact of SOX6 on the expressions of SOX4 and SOX9 in ccRCC cell lines.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Besides, overexpression of SOX9 is related to clinicopathological characteristics, such as the advanced pathological grade and clinical stage. Also, SOX9 is an independent predictor factor for the survival of RCC patients in the TCGA dataset [27].…”
Section: Sox9 Is Overexpressed In Crc Tumors and Cell Linesmentioning
confidence: 98%